Comparative pilot study of repeated large volume paracentesis vs the combination on clonidine-spironolactone in the treatment of cirrhosis-associated refractory ascites

Gastroenterologie Clinique et Biologique

Volumn 29, Issue 11, 2005, Pages 1137-1142

  Lenaerts, Anne ^a   Codden, Thierry ^a   Henry, Jean Pol ^a   Legros, Franz ^b   Ligny, Gaston ^a  

^a Centre Hospitalier Universitaire de Charleroi   (Belgium)

^b CHU Andre Vesale   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CLONIDINE; NEUROHORMONE; SPIRONOLACTONE;

ADULT; ARTICLE; ASCITES; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVER CIRRHOSIS; MALE; PARACENTESIS; PILOT STUDY; SHORT COURSE THERAPY; SYMPATHETIC TONE; WEIGHT REDUCTION;

EID: 30044442492     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(05)82178-5     Document Type: Article

References (23)

1. Gines P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991 ;325:829-35.
2. Le Moine O, Nevens F. TIPS for refractory ascites. A Belgian two center experience. Acta Gastroenterol Belg 1996 ;59:207.
3. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilatation hypothesis. A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988 ;8:1151-57.
4. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996 ;23:164-76.
5. Henriksen JH, Ring-Larsen H. Hepatorenal disorders: Role of the sympathetic nervous system. Sem Liver Dis 1994 ;14:35-43.
6. Lenaerts A, Codden Th, Henry JP Van Cauter J, Meunier JC, Ligny G. Biological factors influencing response to diuretics in patients with cirrhosis and ascites. Gastroenterol Clin Biol 2001 ;25:268-72.
7. Goldstein DS, Levinson PD, Zimlichman R, Pitterman A, Stull R, Keiser HR, et al. Clonidine suppression testing in essential hypertension. Ann Intern Med 1985 ;102:42-8.
8. Moreau R, Lee SS, Hadengue A, Braillon A, Lebrec D. Hemodynamic effects of a Clonidine-induced decrease in sympathetic tone in patients with cirrhosis. Hepatology 1987 ;7:149-54.
9. Lenaerts A, Van Cauter J, Moukhaiber H, Meunier JC, Ligny G. Treatment of refractory ascites with clonidine and spironolactone. Gastroent Clin Biol 1997 ;21:524-25.
10. Lenaerts A, Codden T, Van Cauter J, Meunier JC, Henry JP, Ligny G. Interest of the association clonidine-spironolactone in cirrhotic patients with ascites and activation of sympathetic nervous system. Acta Gastroenterol Belg 2002 ;65:1-5.
11. Gines P, Tito L, Arroyo V, Planas R, Panes J, Viver J, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988;94:1493-502.
12. Zuo WM, Pratt RE, Heusser CH, Bews JP, de Gasparo MM, Dzau VJ. Characterization of monoclonal antibody specific for human active renin. Hypertension 1992 ;19:249-54.
13. Verma PS, Curry CL, Ahluwalia BS. Simultaneous determination of aldosterone and desoxycorticosterone in human plasma by radioimmunoassay. Analytical Letters 1977 ;10:283-95.
14. Weicher H, Feraudi M, Hägele H, Pluto R. Electrochemical detection of catecholamines in urine and plasma after separation with HPLC. Clinica Chimica Acta 1984 ;141:17-25.
15. Brochner-Mortensen J, Rodbro P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 1974 ;33:31-34.
16. Esler M, Dudley F, Jennings G Debinski H, Lambert G, Jones P, et al. Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. Ann Intern Med 1992 ;116:446-55.
17. Gines P, Arroyo V, Rodes J. Pharmacotherapy of ascites associated with cirrhosis. Drugs 1992 ;43:316-32.
18. Perez-Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology 1983 ;84:961-8.
19. Roulot D, Moreau R, Gaudin C Bacq Y, Braillon A, Hadengue A, et al. Long term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis. Gastroenterology 1992 ;102:1309-18.
20. Kosman ME. Evaluation of clonidine hypochloride (Catapres). A new antihypertensive agent. Jama 1975 ;233:174-6.
21. Pettinger WA, Keeton TK, Campbell WB, Harper DC. Evidence for a renal alpha-adrenergic receptor inhibiting renin release. Circ Res 1976 ;38:338-46.
22. Niarchos AP, Baer L, Radichevich I. Role of renin and aldosterone suppression in the antihypertensive mechanism of clonidine. Am J Med 1978 ;65:614-8.
23. Weber MA, Case DB, Baer L, Sealey JE, Drayer JI, Lopez-Overjero JA, et al. Renin and aldosterone suppression in the antihypertensive action of clonidine. Am J Cardiol 1976 ;38:825-30.